Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III placebo-controlled trial of topical miltefosine for breast cancer skin lesions
ISRCTN91258120Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Jan 1998
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Miltefosine 6% solution with Placebo solution (2 arms). Primary endpoint: Time to treatment failure. Started Jan 1998; status: completed.
02
Drugs
miltefosine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN91258120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91258120.